MUMBAI, India, Oct. 24 -- Intellectual Property India has published a patent application (202421031908 A) filed by Regrow Biosciences Private Limited, Pune, Maharashtra, on April 22, 2024, for 'a method for inducing tissue regeneration and treating autoimmune diseases using mesenchymal stem cells.'
Inventor(s) include Sanghavi, Satyen; and Kedage, Vinayak.
The application for the patent was published on Oct. 24, under issue no. 43/2025.
According to the abstract released by the Intellectual Property India: "The present disclosure relates to a method of inducing tissue regeneration, said 5 method comprising administering to said tissue a composition comprising a population of mesenchymal stem cells (MSCs) and a carrier, wherein said composition possess an inherent ability to reduce inflammation by increasing levels of IL-10 and decreasing levels of TNF-a and IL-6. The present disclosure also relates to a method of treating an autoimmune disease through regeneration of 10 cartilage and bone tissues in a subject, the method comprising: administering therapeutic amount of a composition comprising a population of mesenchymal stem cells (MSCs) and a carrier to the subject by intra-plantar route, intravenous route, intramuscular route, intraarticular route, intraosseous route, or subcutaneous route; wherein said population of MSCs is a homogeneous population having a size in the 15 range of 15-30 m; and wherein said composition comprises secretome of said MSCs having VEGF and IL-10. 20 41."
Disclaimer: Curated by HT Syndication.
